🇺🇸 US

ABT revenue, net income and debt history (Abbott Laboratories)

Quick answer

Abbott Laboratories (ABT) reported revenue of $44.33B and net income of $6.52B for the fiscal year ended 2025-12-31, up 5.7% from $41.95B the year before, per its 10-K filed with the SEC on 2026-02-20. Long-term debt stood at $12.93B.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Fiscal yearRevenueNet incomeLong-term debt
2025 (FY ending 2025-12-31)$44.33B$6.52B$12.93B
2024 (FY ending 2024-12-31)$41.95B$13.40B$14.12B
2023 (FY ending 2023-12-31)$40.11B$5.72B$14.68B
2022 (FY ending 2022-12-31)$43.65B$6.93B$16.77B
2021 (FY ending 2021-12-31)$43.08B$7.07B$18.05B
2020 (FY ending 2020-12-31)$34.61B$4.50B$18.53B
2019 (FY ending 2019-12-31)$31.90B$3.69B$17.94B
2018 (FY ending 2018-12-31)$30.58B$2.37B$19.37B
2017 (FY ending 2017-12-31)$27.39B$477.0M$27.72B
2016 (FY ending 2016-12-31)$20.85B$1.40B$20.68B

Related

Last updated 2026-10-16. Data only, not financial or tax advice.